Market Overview

TherapeuticsMD, an Innovative Women's Healthcare Company, and PlushCare, a Virtual Health Platform, Announce Enhanced Access to Women's Health Products

Share:

Arrangement advances access to quality healthcare for women

TherapeuticsMD, Inc. (NASDAQ:TXMD), an innovative women's healthcare
company, and PlushCare, a virtual health platform that enables patients
to book a virtual doctor's appointment to get treatment, today announced
that TherapeuticsMD's women's health products can be prescribed to
patients via the PlushCare platform.

This press release features multimedia. View the full release here:
https://www.businesswire.com/news/home/20200107005077/en/

"We are excited that women have an option to receive care via the
PlushCare virtual care platform, which provides a convenient alternative
for women to connect and talk to a doctor about menopausal and
reproductive treatment options," said TherapeuticsMD Chief Commercial
Officer Dawn Halkuff.

"Oftentimes women's health problems can be easily dismissed or
overlooked, and now with companies like TherapeuticsMD, women's health
is being taken more seriously. We are extremely proud and excited to
offer access to products like TherapeuticsMD's as we are continuously
working to meet the demands of our patients," said PlushCare co-founder
and CEO, Ryan McQuaid.

PlushCare is a virtual health platform offering affordable primary care
medical services to patients in all 50 U.S. states. Having treated over
100,000 patients and diagnosed over 3,500 medical conditions, PlushCare
is changing the medical landscape and offering affordable and accessible
healthcare to all.

For more information on PlushCare or TherapeuticsMD, please visit
Plushcare.com or TherapeuticsMD.com.

About PlushCare:

PlushCare is a virtual health platform that offers primary healthcare
and virtual doctor's visits to patients in all 50 U.S. states. With over
100,000 users and counting, patients are connected to physicians from
the top 50 medical institutions in the country via desktop or mobile
devices. PlushCare accepts most major insurance plans, and patients have
access to quality primary care consultations and can get diagnosed,
treated, prescribed medication or have lab testing. The PlushCare
platform for virtual health provides a unique combination of doctors,
on-demand lab testing, affordable pricing, and same-day appointments
with the patient's choice of provider. Treating over 3,500 medical
conditions, PlushCare strives to make patient's healthcare experience
with doctors stress-free and is available on the PlushCare mobile app
for iOS and Android or via PlushCare.com.

About TherapeuticsMD, Inc.

TherapeuticsMD, Inc. is an innovative, leading healthcare company,
focused on developing and commercializing novel products exclusively for
women. Our products are designed to address the unique changes and
challenges women experience through the various stages of their lives
with a therapeutic focus in family planning, reproductive health, and
menopause management. The company is committed to advancing the health
of women and championing awareness of their healthcare issues. To learn
more about TherapeuticsMD, please visit www.therapeuticsmd.com
or follow us on Twitter: @TherapeuticsMD and on Facebook: TherapeuticsMD.

Forward-Looking Statements

This press release by TherapeuticsMD, Inc. may contain forward-looking
statements. Forward-looking statements may include, but are not limited
to, statements relating to TherapeuticsMD's objectives, plans and
strategies as well as statements, other than historical facts, that
address activities, events or developments that the company intends,
expects, projects, believes or anticipates will or may occur in the
future. These statements are often characterized by terminology such as
"believes," "hopes," "may," "anticipates," "should," "intends," "plans,"
"will," "expects," "estimates," "projects," "positioned," "strategy" and
similar expressions and are based on assumptions and assessments made in
light of management's experience and perception of historical trends,
current conditions, expected future developments and other factors
believed to be appropriate. Forward-looking statements in this press
release are made as of the date of this press release, and the company
undertakes no duty to update or revise any such statements, whether as a
result of new information, future events or otherwise. Forward-looking
statements are not guarantees of future performance and are subject to
risks and uncertainties, many of which are outside of the company's
control. Important factors that could cause actual results, developments
and business decisions to differ materially from forward-looking
statements are described in the sections titled "Risk Factors" in the
company's filings with the Securities and Exchange Commission, including
its most recent Annual Report on Form 10-K and Quarterly Reports on Form
10-Q, as well as reports on Form 8-K, and include the following: the
company's ability to maintain or increase sales of its products; the
company's ability to develop and commercialize IMVEXXY®,
ANNOVERA, BIJUVA® and its hormone therapy drug
candidates and obtain additional financing necessary therefor; whether
the company will be able to comply with the covenants and conditions
under its term loan facility, including the conditions to draw
additional tranches thereunder; the potential of adverse side effects or
other safety risks that could adversely affect the commercialization of
the company's current or future approved products or preclude the
approval of the company's future drug candidates; the length, cost and
uncertain results of future clinical trials; the company's reliance on
third parties to conduct its manufacturing, research and development and
clinical trials; the ability of the company's licensees to commercialize
and distribute the company's products; the availability of reimbursement
from government authorities and health insurance companies for the
company's products; the impact of product liability lawsuits; the
influence of extensive and costly government regulation; the volatility
of the trading price of the company's common stock and the concentration
of power in its stock ownership. PDF copies of the company's historical
press releases and financial tables can be viewed and downloaded at its
website: www.therapeuticsmd.com/pressreleases.aspx.

View Comments and Join the Discussion!
 
Don't Miss Any Updates!
News Directly in Your Inbox
Subscribe to:
Benzinga Premarket Activity
Get pre-market outlook, mid-day update and after-market roundup emails in your inbox.
Market in 5 Minutes
Everything you need to know about the market - quick & easy.
Fintech Focus
A daily collection of all things fintech, interesting developments and market updates.
Thank You

Thank you for subscribing! If you have any questions feel free to call us at 1-877-440-ZING or email us at vipaccounts@benzinga.com